Dec 1 (Reuters) - Pfizer Inc said on Wednesday it had started the real-time submission of its application seeking Health Canada's approval of its oral COVID-19 antiviral drug candidate.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Amy Caren Daniel)